Premium
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease
Author(s) -
Qureshi Amrana,
Kaya Banu,
Pancham Shivan,
Keenan Russell,
Anderson Jeremy,
Akanni Magbor,
Howard Jo
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15235
Subject(s) - hydroxycarbamide , medicine , disease , pediatrics , intensive care medicine
Department of Paediatric Haematology and Oncology, Oxford Children’s Hospital, Oxford University Hospital NHS Trust, Oxford, Department of Paediatric Haematology and Oncology, Royal London Hospitals, Barts Health NHS Trust, London, Department of Haematology, Sandwell and West Birmingham NHS Trust, West Bromwich, Department of Paediatric Haematology, Alderhey Children’s Hospital NHS Trust, Liverpool, Department of Clinical Psychology, Imperial College Healthcare NHS Trust, London, Department of Haematology, Milton Keynes Hospital NHS Trust, Milton Keynes, and Department of Haematology, Guys and St Thomas’s NHS Foundation Trust, London, UK